Staphylococcus aureus represents one of the leading causes of mastitis in dairy cows worldwide. S. aureus IMI have variable outcomes due to virulence of the strain involved, immune defenses of the host, and by antibiotic resistance. The difficulty in eradication and the increasing concerns on antibiotics usages underscore the interest in developing new tools to control S. aureus mastitis. Vaccination represents one of the most studied of these tools but, so far, no vaccine seems to provide reliable protection. This review summarizes current knowledge on the major vaccine targets, including surface proteins, capsular polysaccharides, biofilm, and toxins. Finally, the present status of vaccination against S. aureus and the future of vaccine design were discussed, including how differences among in vivo models may influence vaccines development.
Which are important targets in development of S. aureus mastitis vaccine? / F. Scali, C.Camussone, L.S. Calvinho, M. Cipolla, A. Zecconi. - In: RESEARCH IN VETERINARY SCIENCE. - ISSN 0034-5288. - 100:(2015 Jun 01), pp. 88-99. [10.1016/j.rvsc.2015.03.019]
Which are important targets in development of S. aureus mastitis vaccine?
M. CipollaPenultimo
;A. Zecconi
2015
Abstract
Staphylococcus aureus represents one of the leading causes of mastitis in dairy cows worldwide. S. aureus IMI have variable outcomes due to virulence of the strain involved, immune defenses of the host, and by antibiotic resistance. The difficulty in eradication and the increasing concerns on antibiotics usages underscore the interest in developing new tools to control S. aureus mastitis. Vaccination represents one of the most studied of these tools but, so far, no vaccine seems to provide reliable protection. This review summarizes current knowledge on the major vaccine targets, including surface proteins, capsular polysaccharides, biofilm, and toxins. Finally, the present status of vaccination against S. aureus and the future of vaccine design were discussed, including how differences among in vivo models may influence vaccines development.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S0034528815000934-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
471.39 kB
Formato
Adobe PDF
|
471.39 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.